Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics.

Arasanz, Hugo; Zuazo, Miren; Bocanegra, Ana; Gato, María; Martínez-Aguillo, Maite; Morilla, Idoia; Fernández, Gonzalo; Hernández, Berta; López, Paúl; Alberdi, Nerea; Hernández, Carlos; Chocarro, Luisa; Teijeira, Lucía; Vera, Ruth; Kochan, Grazyna; Escors, David

Arasanz, Hugo; Zuazo, Miren; Bocanegra, Ana; Gato, María; Martínez-Aguillo, Maite; Morilla, Idoia; Fernández, Gonzalo; Hernández, Berta; López, Paúl; Alberdi, Nerea; Hernández, Carlos; Chocarro, Luisa; Teijeira, Lucía; Vera, Ruth; Kochan, Grazyna; Escors, David.

Afiliação

Arasanz H; Oncoimmunology Group, Navarrabiomed, Instituto de Investigaciones Sanitarias de Navarra (IdISNA) UPNA, Irunlarrea st, 3, 31008 Pamplona, Spain.
Zuazo M; Department of Medical Oncology, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain.
Bocanegra A; Oncoimmunology Group, Navarrabiomed, Instituto de Investigaciones Sanitarias de Navarra (IdISNA) UPNA, Irunlarrea st, 3, 31008 Pamplona, Spain.
Gato M; Oncoimmunology Group, Navarrabiomed, Instituto de Investigaciones Sanitarias de Navarra (IdISNA) UPNA, Irunlarrea st, 3, 31008 Pamplona, Spain.
Martínez-Aguillo M; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Instituto de Investigaciones Sanitarias de Navarra (IdISNA), University of Navarra, Pio XII ave, 55, 31008 Pamplona, Spain.
Morilla I; Department of Medical Oncology, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain.
Fernández G; Department of Medical Oncology, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain.
Hernández B; Oncoimmunology Group, Navarrabiomed, Instituto de Investigaciones Sanitarias de Navarra (IdISNA) UPNA, Irunlarrea st, 3, 31008 Pamplona, Spain.
López P; Department of Medical Oncology, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain.
Alberdi N; Department of Medical Oncology, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain.
Hernández C; Radiology Department, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain.
Chocarro L; Radiology Department, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain.
Teijeira L; Oncoimmunology Group, Navarrabiomed, Instituto de Investigaciones Sanitarias de Navarra (IdISNA) UPNA, Irunlarrea st, 3, 31008 Pamplona, Spain.
Vera R; Oncoimmunology Group, Navarrabiomed, Instituto de Investigaciones Sanitarias de Navarra (IdISNA) UPNA, Irunlarrea st, 3, 31008 Pamplona, Spain.
Kochan G; Department of Medical Oncology, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain.
Escors D; Department of Medical Oncology, Complejo Hospitalario de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IdISNA), Irunlarrea st, 3, 31008 Pamplona, Spain.

Cancers (Basel) ; 12(2)2020 Feb 04.

Article em En | MEDLINE | ID: mdl-32033028

Palavras-chave

NSCLC; hyperprogressive disease; immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google